Oncology Pharma Inc. announced that Vijay Mahant (M.S, Ph.D.) has been appointed as the Chief Scientific Officer (CSO) of Oncology Pharma and its Chief Operating Officer (COO). Dr. Mahant is a scientist and an entrepreneur with about 35 years of experience in biotechnology. He brings vast knowledge and experience in both R&D, business and management. Mahant is a founder of MediLite Diagnostika, a former CSO and VP of R&D at Qualigen and a former executive VP of R&D at AutoGenomics. Dr. Mahant has held senior R&D positions and management positions at Nichols Institute/Quest Diagnostics and Igen International. He holds numerous international patents and he is on the Scientific Advisory Board of biotechnology companies such as Trutino Biosciences and Immunicom Inc.